Merck successfully completed its $10 billion acquisition of Verona Pharma last month, a deal notable for the absence of a... Read more
Category: Uncategorized
Johnson & Johnson Expands Neuroscience Portfolio with $14.6 Billion Acquisition
Global healthcare leader Johnson & Johnson (J&J) commenced the J.P. Morgan Healthcare Conference by announcing its intent to acquire Intra-Cellular... Read more
Pharmaceutical Giant Finalizes Acquisition of Obesity Drug Developer
The global pharmaceutical corporation Pfizer Inc. has announced the successful conclusion of its acquisition of the clinical-stage biotechnology firm, Metsera,... Read more
Vetter Managing Director to Retire Following Over Three Decades of Service
Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has announced the retirement of its Managing Director, Thomas Otto,... Read more
New Study Suggests Shingles Vaccine May Slow Cognitive Decline
A new follow-up study, published in the journal Cell, adds evidence that the shingles vaccine, a two-dose shot recommended for... Read more
Bristol Myers Bolsters Scale of Cobenfy Trial After Discovery of Site Irregularities
Bristol Myers Squibb (BMS) has announced an extension and increased enrollment for its late-stage clinical trial, “ADEPT-2,” of the drug... Read more
Senior FDA Drug Regulator Steps Down Shortly After Appointment
The U.S. Food and Drug Administration (FDA) is once again searching for a leader for its Center for Drug Evaluation... Read more
AI Chemistry Outfit Secures $95 Million to Accelerate Small Molecule Discovery and Production
Excelsior Sciences, an artificial intelligence (AI) chemistry firm, is gaining ground on its mission to hasten the discovery and production... Read more
Campaign Raises Vision Health Awareness Targeting Aging Women
The Johnson & Johnson (J&J) corporation has teamed up with the acclaimed actress Naomi Watts in a communication campaign to... Read more









